<DOC>
	<DOCNO>NCT01008436</DOCNO>
	<brief_summary>The study enroll consecutive patient undergo cardiac surgery European Hospital , Rome . The population undergoes randomization receive usual surgical hemostasis add topical application Omni-stat Celox . The two population follow prospectively regard blood loss need blood transfusion , well adverse event 30 day surgery .</brief_summary>
	<brief_title>Blood Sparing Strategies : Omni-stat Routinary Use Cardiac Surgery . A Prospective Randomized Study .</brief_title>
	<detailed_description />
	<mesh_term>Chitosan</mesh_term>
	<criteria>All patient undergoing heart surgery</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Ability topical drug reduce acute overall bleeding well blood transfusion</keyword>
</DOC>